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The genus Globularia (Globulariaceae) is represented by
eight species in the flora of Turkey.1) In Anatolian folk medi-
cine, G. alypum is used as a diuretic, laxative, stomachic 
and tonic,2) while G. trichosantha is utilized for the treatment
of hemorrhoids.3) In our previous papers, we reported
phenylethanoid glycosides, iridoid and bisiridoid glycosides
from G. trichosantha.4,5) In the continuation of chemical
studies of Turkish Globularia species, we have investigated
an endemic species, G. davisiana. We herein present the iso-
lation and structure elucidation of davisioside (1), a new iri-
doid glycoside with a saturated D3,4 obtained from the aerial
parts of G. davisiana.
Davisioside (1) was obtained as an amorphous powder.
The molecular formula, C22H28O10, requiring nine degrees of
unsaturation, was deduced by a combination of electrospray
ionization mass spectroscopy (ESI-MS) (m/z 475, [M1
Na]1), high resolution (HR)-FAB-MS (m/z 435.1675, [M2
H2O1H]
2) and 13C-NMR data. Compound 1 exhibited UV
maxima at 229 and 274 nm. The IR spectrum suggested the
presence of hydroxyl (3421 cm21), ester carbonyl (1715
cm21), olefinic (1654 cm21) and aromatic (1508, 1451 cm21)
functionalities. The 1H-NMR spectrum (Table 1) contained
signals due to an olefinic proton (dH 5.86), an acetal proton
(dH 4.96), an oxygenated methine proton (dH 4.56), two
oxymethylenes (dH 3.99 and 3.58; dH 5.08 and 4.94), two
methines (dH 2.43, 2.86) and two diastereopic protons of a
methylene (dH 1.66, 1.81). Additional aromatic proton sig-
nals at dH 8.06 (2H), 7.62 (1H) and 7.49 (2H) and the corre-
sponding carbon resonances (Table 1) were typical of a
monosubstituted phenyl moiety. The signals in the region of
dH 3.20—3.80 (6H) accompanied by an anomeric proton res-
onance at dH 4.60 (d, J57.8 Hz) supported that 1 contained a
b-glucopyranosyl unit. The 13C-NMR spectrum of 1 dis-
played 22 signals, six of which could be attributed to a b-glu-
copyranosyl unit, while seven of which were ascribed to a
benzoic acid moiety. All the remaining 13C signals, estab-
lished by distortionless enhancement by polarization transfer
(DEPT)-90, DEPT-135, gradient heteronuclear single quan-
tum coherence (gHSQC) and gradient heteronuclear multiple
bond correlation (gHMBC) experiments, were assignable to
a dihydroaucubin type iridoid core.6) The double quantum fil-
tered correlation spectroscopy (DQF-COSY) spectrum of 1
revealed that two methylene and five methine protons of the
aglycone existed as one proton spin system (Fig. 1). The pro-
ton sequence started with the acetal proton, H-1, which
showed coupling with H-9. The latter proton was further cou-
pled to H-5. Additional scalar couplings were obtained be-
tween H-5/H2-4 and H2-4/H2-3. In the other direction, H-5
correlated to a b-hydroxy bearing proton (dH 4.56, H-6),
which further coupled to the olefinic proton, H-7. The ab-
sence of any other homonuclear couplings observed for H-7
was indicative of C-8 being fully substituted. The gHMBC
spectrum (Table 1) allowed assignment of the remainder of
the aglycone, where the expected long-range couplings for
dihydroaucubin were observed (Table 1). However, the pro-
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Fig. 1. COSY and Some Selected HMBC Correlations for 1
ton signals assigned to H2-10 appeared to be deshielded. This
finding, together with the gHMBC correlation between H2-10
and the carbonyl carbon of the benzoic acid suggested C-10
to be the site of acylation. The gHMBC correlations between
H-1 and C-19 and vice versa, indicated that the b-glucopyra-
nosyl unit was attached at the usual position, C-1. To prove
the relative stereochemistry of the chiral centers in 1, a two-
dimensional nuclear Overhauser effect spectroscopy (2D
NOESY) experiment was performed. NOe cross-peaks of
significant intensity between H-9/H-5, H-5/H-4b , and H-
4b /H-3b indicated these protons to lie on the same side (b)
of the molecule. Contrary, prominent nOe correlations were
observed between H-1/H-3a and H-3a /H-4a and H-4a /H-
6a . Therefore, the secondary alcohol functions at C-1 and C-
6 had to be in the b position. These data also confirmed the
cis fusion of the cyclopentan and pyran rings as expected.
Consequently, the structure of 1 was established as 10-O-
benzoyl-3,4-dihydroaucubin. 
The NMR and MS data for asperuloside (2),7) alpinoside
(3),8) geniposide (4),9) globularin (5),10) globularicisin (6),10)
10-O-benzoylcatalpol (7),11) lytanthosalin (8),12) melampyro-
side (9),13) agnuside (10),14,15) as well as verbascoside,16)
isoacteoside,17) and leucosceptoside A18) were identical with
published data. All isolates were tested for their radical 
scavenging activity using 2,2-diphenyl-1-picrylhydrazyl
(DPPH).19,20) Only the phenylethanoid glycosides were found
to possess antioxidant property (yellow-on-purple spot).
Davisioside (1) represents a rare iridoid skeleton lacking
the double bond between C-3 and C-4. Globularidin, isolated
from Globularia alypum,21) was the first reported iridoid gly-
coside with such an aglycone. Globularidin has also been
isolated from G. trichosantha.5) Therefore, it is possible that
this type of iridoids are common in the family Globulari-
aceae.
Experimental 
Optical rotation was measured on a JASCO DIP-370 digital polarimeter
using a sodium lamp operating at 589 nm. UV spectrum was recorded on a
Shimadzu UV-160A spectrophotometer. IR spectrum (KBr) was measured
on a Perkin Elmer 2000 FT-IR spectrometer. NMR measurements in CD3OD
were performed on a Varian unit, operating at 400 MHz for 1H and 100 MHz
for 13C. Negative- and positive-mode ESI-MS were recorded on a Finnigan
TSQ 7000 instrument. FAB-MS measurements were performed on a Finni-
gan MAT95 spectrometer. TLC analyses were carried out on silica gel 60
F254 precoated plates (Merck, Darmstadt); detection by 1% vanillin/H2SO4.
For medium pressure liquid chromatography (MPLC) separations, a Lewa
M5 pump, a LKB 17000 Minirac fraction collector, a Rheodyne injector,
and a Büchi column (column dimensions 2.6346 cm, and 1.8335 cm) were
used. Silica gel 60 (0.063—0.200 mm; Merck, Darmstadt) was used for
open column chromatography (CC) and vacuum liquid chromatography
(VLC). MPLC separations were performed over LiChroprep C-18 (Merck)
material. 
Plant Material G. davisiana O. SCHWARZ was collected from Antalya,
Beldibi, in South Anatolia, Turkey, in June 2000. The voucher specimen
(HUEF 00286) has been deposited at the Herbarium of the Department of
Pharmacognosy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Extraction and Isolation The air-dried aerial parts (250 g) of G.
davisiana were extracted with EtOH (232 l) at 45 °C. The combined
ethanolic extracts were dried in vacuo (53 g, yield 21%). The crude extract
was dissolved in H2O and partitioned between CH2Cl2 and n-BuOH. An
aliquot (21 g) of the lyophilized n-BuOH phase (30 g) was fractionated over
SiO2 (VLC). Employment of CH2Cl2–MeOH–H2O mixtures (90 : 10 : 1 to
60 : 40 : 4) afforded nine main fractions, A-I. Fraction B (2.93 g) was sub-
jected to reverse phase (RP)-MPLC using step gradient MeOH in H2O (30—
100%) to yield 8 (150 mg) and four additional fractions, B1—B4. Fraction B2
(80 mg) was rechromatographed on SiO2 eluting with CH2Cl2–MeOH–H2O
(90 : 10 : 1) to give 6 (30 mg). Fraction B4 (1.8 g) was also fractionated by
RP-MPLC using iso-PrOH gradients in H2O (10—30%) to yield 9 (40 mg)
and fr B4b (1.0 g), separation of which was carried out by SiO2 CC to give 5
(67 mg). Fraction D (2.5 g) likewise was subjected to RP-MPLC (20—50%
MeOH) to yield compounds 3 (7 mg), 2 (18 mg), in addition to frs. D3—D10.
Purification of fr. D4 (106 mg) and fr. D6 (227 mg) by SiO2 CC furnished 4
(63 mg) and 7 (103 mg), respectively. Leucosceptoside A (13 mg) was also
purified by SiO2 CC from fr. D8 (97 mg) by employing an isocratic elution 
of CHCl3–MeOH–H2O (80 : 20 : 2). Fraction D9 (152 mg) was also subjected
to gradient CC over SiO2 (CHCl3–MeOH–H2O, 85 : 10 : 1 to 80 : 20 : 1) to
yield frs. D9a (40 mg) and D9b (52 mg). Repeated chromatography of fr. D9a
on a SiO2 column using CHCl3–MeOH–H2O (80 : 15 : 1) gave 1 (24 mg).
Melampyroside (9, 134 mg) was obtained from fr. D10 (370 mg) by SiO2 CC,
employing CHCl3–MeOH–H2O (90 : 10 : 1 to 80 : 20 : 2) as mobile phase.
Fraction E (3.3 g) was subjected to RP-MPLC using stepwise gradients of
MeOH (5—70%) in H2O and yielded seven main fractions, E1—E7. Fraction
E4 (505 mg) was rechromatographed on SiO2 (CHCl3–MeOH–H2O, 80 :
20 : 2 to 61 : 32 : 7) to give frs. E4a (20 mg) and E4b (313 mg). Repeated CC
of fr. E4a over SiO2 afforded 10 (6 mg). Fraction E4b was further purified by
RP-MPLC using H2O–MeOH mixtures (10—40% MeOH) to yield verbas-
coside (55 mg). An aliquot (47 mg) of the fr. E6 (131 mg) was applied to a
SiO2 column. Elution with CHCl3–MeOH–H2O (80 : 15 : 1 to 80 : 20 : 2)
yielded isoacteoside (8 mg).
Davisioside (1): Amorphous white powder, [a]D 269° (c50.48, MeOH);
ESI-MS m/z 475 [M1Na]1; FAB-MS m/z: 435 [M2H2O1H]
1 (5), 273
(16), 255 (87), 185 (63), 149 (65), 93 (100); HR-FAB-MS m/z: 435.1675,
Calcd for C22H27O9 435.1655; UV lmax (MeOH, nm): 229, 274; IR nmax
(KBr, cm21): 3421, 1715, 1654, 1508, 1451; 1H-NMR (CD3OD, 400 MHz)
Table 1; 13C-NMR (CD3OD, 100 MHz) Table 1.
Reduction of DPPH Radical Methanolic solutions (0.1%) of all iso-
lates were chromatographed on a Si gel TLC plate using CHCI3–MeOH–
H2O (61 : 32 : 7) solvent system. After drying, TLC plates were sprayed with
a 0.2% DPPH (Fluka) solution in MeOH. Compounds showing a yellow-on-
purple spot were regarded as antioxidant.20)
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Table 1. 13C- (100 MHz), 1H-NMR (400 MHz) and Complete gHMBC
(J58 Hz) Data for Davisioside (1) in CD3OD
a)
C/H dC ppm DEPT dH ppm, J (Hz) HMBC (H fi C)
1 95.5 CH 4.96 d (6.0) C-19, C-3
3a 61.7 CH2 3.99 m C-1, C-5
3b 3.58 m
4a 25.3 CH2 1.66 m
4b 1.81 m
5 46.1 CH 2.43 m C-3, C-4, C-6, C-9
6 79.3 CH 4.56 br d (5.5) C-8
7 132.2 CH 5.86 br s C-5, C-6, C-8, C-9, C-10
8 143.8 C
9 48.6 CH 2.86 t (6.0) C-1, C-5, C-6, C-7, C-8
10 63.9 CH2 5.08 d (14.7) C-7, C-8, C5O
4.94 d (14.7)
19 99.6 CH 4.60 d (7.8) C-1
29 74.9 CH 3.20 dd (7.8, 8.9) C-19, C-39
39 78.1 CH 3.36 t (8.9) C-29
49 71.6 CH 3.26b) C-39, C-59
59 78.2 CH 3.25b) C-69
69 62.8 CH2 3.80 dd (11.9, 1.6) C-59
3.64 dd (11.9, 5.2)
10 131.3 C
20 130.6 CH 8.06 dd (7.4, 1.3) C5O, C-10
30 129.6 CH 7.49 t (7.4) C-10
40 134.4 CH 7.62 tt (7.4, 1.3) C-20, C-60
50 129.6 CH 7.49 t (7.4) C-10
60 130.6 CH 8.06 dd (7.4, 1.3) C5O, C-10
C5O 167.7 C
a) All proton and carbon assignments are based on 2D NMR (DQF-COSY, 
gHSQC and gHMBC) experiments. b) Signal patterns are unclear due to overlap-
ping.
Utah, for recording mass spectra. 
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